Evidence map›Paper›PMID 37982235›Full record

ArticleRenal failure2023

Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease.

Andrea Angioi, Matteo Floris, Nicola Lepori, Gianfranca Cabiddu, Antonello Pani

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Renal failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andrea AngioiNephrology, Dialysis and Transplantation Unit, 'Giuseppe Brotzu' Hospital, Cagliari, Italy.
Matteo FlorisNephrology, Dialysis and Transplantation Unit, 'Giuseppe Brotzu' Hospital, Cagliari, Italy.
Nicola LeporiNephrology, Dialysis and Transplantation Unit, 'Giuseppe Brotzu' Hospital, Cagliari, Italy.
Gianfranca CabidduNephrology, Dialysis and Transplantation Unit, 'Giuseppe Brotzu' Hospital, Cagliari, Italy.
Antonello PaniNephrology, Dialysis and Transplantation Unit, 'Giuseppe Brotzu' Hospital, Cagliari, Italy.
Azienda Ospedaliera G. Brotzu · ITUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sodium Zirconium Cyclosilicate (SZC) is commonly used for treating hyperkalemia because it sequesters gastrointestinal potassium ions, thereby reducing serum potassium levels. However, a less-discussed aspect of SZC is its radiopacity on x-ray-based imaging techniques. The European Medicines Agency (EMA) has only vaguely addressed this issue. Radiopaque substances like SZC can interfere with diagnostic imaging, creating challenges for clinicians and radiologists. We present the case of a 34-year-old Italian male to illustrate these concerns.

Indexed as

HyperkalemiaKidney DiseasesAdultHumansMalePotassiumSilicatesTomographyPotassiumSilicatessodium zirconium cyclosilicateChronic Kidney Disease (CKD)Computed Tomography (CT) imagingdiagnostic imaginghyperkalemiaradiopacitySodium Zirconium Cyclosilicate

Identifiers

PMID37982235
PMCPMC11001350
OpenAlexW4388828569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.